Literature DB >> 26298726

The study of MED12 gene mutations in uterine leiomyomas from Iranian patients.

Samaneh Sadeghi1, Mandana Khorrami2, Mona Amin-Beidokhti1, Maryam Abbasi2, Zeeba Kamalian1, Shiva Irani2, Mirdavood Omrani1, Ozra Azmoodeh3, Reza Mirfakhraie4,5.   

Abstract

Uterine leiomyomas are the most common gynecologic benign tumors of the female genital tract that cause a variety of health problems including, abnormal menstrual bleeding, pelvic pain, placenta displacement, premature labor, and miscarriages. Recently, studies showed that recurrent somatic mutations in MED12 exon 2 are the major cause of uterine leiomyomas in different ethnic groups. In order to validate these results in Iranian population, we performed mutational analysis of exon 2 and the flanking intronic regions by using single-strand conformational polymorphism (SSCP) and sequencing analyses in a series of 103 uterine leiomyomas samples. MED12 gene was mutated in 31.07 % of the uterine leiomyomas. Mutations were consisted of 20 missense (62.5 %) and 12 in-frame deletion (37.5 %) mutations and were not detected in normal myometrial tissue. Although this is the lowest mutation frequency reported so far, MED12 mutations are associated with fibroid pathogenesis in the studied population. Understanding the molecular mechanisms responsible for the pathogenesis of uterine leiomyoma will play an important role in designing new therapeutic strategies.

Entities:  

Keywords:  MED12 gene; Mutation; Uterine leiomyomas

Mesh:

Substances:

Year:  2015        PMID: 26298726     DOI: 10.1007/s13277-015-3943-8

Source DB:  PubMed          Journal:  Tumour Biol        ISSN: 1010-4283


  24 in total

1.  Mediator is a transducer of Wnt/beta-catenin signaling.

Authors:  Seokjoong Kim; Xuan Xu; Andreas Hecht; Thomas G Boyer
Journal:  J Biol Chem       Date:  2006-03-24       Impact factor: 5.157

2.  The associations between the polymorphisms of the ER-α gene and the risk of uterine leiomyoma (ULM).

Authors:  Yi Feng; Xiaojuan Lin; Shengtao Zhou; Ning Xu; Tao Yi; Xia Zhao
Journal:  Tumour Biol       Date:  2013-06-09

Review 3.  CDK8: a positive regulator of transcription.

Authors:  Matthew D Galbraith; Aaron J Donner; Joaquín M Espinosa
Journal:  Transcription       Date:  2010 Jul-Aug

4.  Mutations in Exon 1 highlight the role of MED12 in uterine leiomyomas.

Authors:  Kati Kämpjärvi; Min Ju Park; Miika Mehine; Nam Hee Kim; Alison D Clark; Ralf Bützow; Tom Böhling; Jan Böhm; Jukka-Pekka Mecklin; Heikki Järvinen; Ian P M Tomlinson; Zephne M van der Spuy; Jari Sjöberg; Thomas G Boyer; Pia Vahteristo
Journal:  Hum Mutat       Date:  2014-07-21       Impact factor: 4.878

5.  MED12 mutations in uterine fibroids--their relationship to cytogenetic subgroups.

Authors:  Dominique Nadine Markowski; Sabine Bartnitzke; Thomas Löning; Norbert Drieschner; Burkhard Maria Helmke; Jörn Bullerdiek
Journal:  Int J Cancer       Date:  2012-02-28       Impact factor: 7.396

6.  Novel MED12 gene somatic mutations in women from the Southern United States with symptomatic uterine fibroids.

Authors:  Sunil K Halder; Archana Laknaur; Jessica Miller; Lawrence C Layman; Michael Diamond; Ayman Al-Hendy
Journal:  Mol Genet Genomics       Date:  2014-10-18       Impact factor: 3.291

7.  MED12 exon 2 mutations in histopathological uterine leiomyoma variants.

Authors:  Netta Mäkinen; Pia Vahteristo; Kati Kämpjärvi; Johanna Arola; Ralf Bützow; Lauri A Aaltonen
Journal:  Eur J Hum Genet       Date:  2013-02-27       Impact factor: 4.246

8.  Uterine leiomyoma-linked MED12 mutations disrupt mediator-associated CDK activity.

Authors:  Mikko Turunen; Jason M Spaeth; Salla Keskitalo; Min Ju Park; Teemu Kivioja; Alison D Clark; Netta Mäkinen; Fangjian Gao; Kimmo Palin; Helka Nurkkala; Anna Vähärautio; Mervi Aavikko; Kati Kämpjärvi; Pia Vahteristo; Chongwoo A Kim; Lauri A Aaltonen; Markku Varjosalo; Jussi Taipale; Thomas G Boyer
Journal:  Cell Rep       Date:  2014-04-18       Impact factor: 9.423

9.  Risk of uterine leiomyomata in relation to tobacco, alcohol and caffeine consumption in the Black Women's Health Study.

Authors:  Lauren A Wise; Julie R Palmer; Bernard L Harlow; Donna Spiegelman; Elizabeth A Stewart; Lucile L Adams-Campbell; Lynn Rosenberg
Journal:  Hum Reprod       Date:  2004-06-24       Impact factor: 6.918

10.  MED12 exon 2 mutations are common in uterine leiomyomas from South African patients.

Authors:  Netta Mäkinen; Hanna-Riikka Heinonen; Shane Moore; Ian P M Tomlinson; Zephne M van der Spuy; Lauri A Aaltonen
Journal:  Oncotarget       Date:  2011-12
View more
  8 in total

1.  MED12 Exon 1 Mutational Screening in Iranian Patients with Uterine Leiomyoma.

Authors:  Mojdeh Akbari; Atieh Abedin Do; Fakhrolmolouk Yassaee; Reza Mirfakhraie
Journal:  Rep Biochem Mol Biol       Date:  2019-04

2.  Mediator Kinase Disruption in MED12-Mutant Uterine Fibroids From Hispanic Women of South Texas.

Authors:  Min Ju Park; Hailian Shen; Nam Hee Kim; Fangjian Gao; Courtney Failor; Jennifer F Knudtson; Jessica McLaughlin; Sunil K Halder; Tuomas A Heikkinen; Pia Vahteristo; Ayman Al-Hendy; Robert S Schenken; Thomas G Boyer
Journal:  J Clin Endocrinol Metab       Date:  2018-11-01       Impact factor: 5.958

Review 3.  Emerging Roles of Long Non-coding RNAs in Uterine Leiomyoma Pathogenesis: a Review.

Authors:  Zahra Falahati; Masoud Mohseni-Dargah; Reza Mirfakhraie
Journal:  Reprod Sci       Date:  2021-04-12       Impact factor: 3.060

4.  Prevalence and clinical significance of mediator complex subunit 12 mutations in 362 Han Chinese samples with uterine leiomyoma.

Authors:  Juan Wu; Yang Zou; Yong Luo; Jiu-Bai Guo; Fa-Ying Liu; Jiang-Yan Zhou; Zi-Yu Zhang; Lei Wan; Ou-Ping Huang
Journal:  Oncol Lett       Date:  2017-05-04       Impact factor: 2.967

5.  Leiomyoma with bizarre nuclei: a morphological, immunohistochemical and molecular analysis of 31 cases.

Authors:  Jennifer A Bennett; Britta Weigelt; Sarah Chiang; Pier Selenica; Ying-Bei Chen; Ann Bialik; Rui Bi; Anne M Schultheis; Raymond S Lim; Charlotte K Y Ng; Vicente Morales-Oyarvide; Robert H Young; Victor E Reuter; Robert A Soslow; Esther Oliva
Journal:  Mod Pathol       Date:  2017-06-30       Impact factor: 7.842

6.  Ectopic expression of CYP24A1 circular RNA hsa_circ_0060927 in uterine leiomyomas.

Authors:  Elnaz Fazeli; Samira Piltan; Hossein Sadeghi; Milad Gholami; Ghasem Azizi-Tabesh; Fakhrolmolook Yassaee; Reza Mirfakhraie
Journal:  J Clin Lab Anal       Date:  2019-11-20       Impact factor: 2.352

Review 7.  Comprehensive Review of Uterine Fibroids: Developmental Origin, Pathogenesis, and Treatment.

Authors:  Qiwei Yang; Michal Ciebiera; Maria Victoria Bariani; Mohamed Ali; Hoda Elkafas; Thomas G Boyer; Ayman Al-Hendy
Journal:  Endocr Rev       Date:  2022-07-13       Impact factor: 25.261

8.  Multiple clinical characteristics separate MED12-mutation-positive and -negative uterine leiomyomas.

Authors:  Hanna-Riikka Heinonen; Annukka Pasanen; Oskari Heikinheimo; Tomas Tanskanen; Kimmo Palin; Jaana Tolvanen; Pia Vahteristo; Jari Sjöberg; Esa Pitkänen; Ralf Bützow; Netta Mäkinen; Lauri A Aaltonen
Journal:  Sci Rep       Date:  2017-04-21       Impact factor: 4.379

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.